Human SCF
Synonyms: c-kit ligand, steel factor, MGF

Recombinant human SCF (stem cell factor) can stimulate growth and activation of mast cells, as well as expansion of hematopoietic stem cells and myeloid, erythroid, or lymphoid progenitors. The c-Kit receptor transmits the SCF signal, which acts at different levels of embryonic and adult hematopoiesis. For successful use in cell culture, differentiation studies, and functional assays, the recombinant protein human SCF has been optimized.

Select a quality grade:
Select a size:
Other sizes

Related products for Human SCF

Product data and images for Human SCF
Figure 1

Human SCF activity assay. The biological activity of Human SCF is determined by proliferation assay using TF-1 cells.

Figure 2

SDS-PAGE of Human SCF, premium grade under reducing (R) and non-reducing (NR) conditions.

Figure 3

Human SCF biological activity. Activity of Human SCF, premium grade (red bar) was compared to another commercially available product (black bar).

Figure 4

Mass spectrometry analysis (ESI-MS) of Human SCF, premium grade. The peak corresponds to the calculated molecular mass of 18585 Da.

Specifications for Human SCF
Overview

Recombinant human SCF (stem cell factor) can stimulate growth and activation of mast cells, as well as expansion of hematopoietic stem cells and myeloid, erythroid, or lymphoid progenitors. The c-Kit receptor transmits the SCF signal, which acts at different levels of embryonic and adult hematopoiesis. For successful use in cell culture, differentiation studies, and functional assays, the recombinant protein human SCF has been optimized.

Applications

Human SCF can be used for a variety of applications, including:

  • Stimulation of proliferation of myeloid, erythroid, and lymphoid progenitors in bone marrow cultures.
  • In vitro expansion of CD34+ hematopoietic progenitor cells.
  • Differentiation of ES-derived cells towards the hematopoietic lineage.
  • Mast cell differentiation and maintenance.
  • Mast cell chemotaxis assays.
Alternative names

c-kit ligand, steel factor, MGF

Detailed product information

Biological activity

Determination method
Proliferation of TF-1 cells (NIBSC 91/682)
Research grade
≥ 2×105 U/mg
Premium grade
≥ 4×105 U/mg (Typical activity 9×105 U/mg)
We measure the biological activity of each batch of MACS Premium-Grade Cytokines and state the results in the Certificate of Analysis (CoA). Based on the lot-specific activity, exact doses of active cytokine can be applied to cell culture experiments. This allows for reproducible cell culture conditions without the need for time-consuming lot-to-lot testing.
Background information

SCF is a hematopoietic growth factor important for the survival, proliferation, and differentiation of hematopoietic stem cells and progenitor cells. Besides its pivotal role in mast cell development, SCF acts as a potent mast cell chemoattractant and upregulates mast cell adhesion and migration. SCF signals through the c-kit receptor (CD117) and exists in two forms; cell surface bound SCF and soluble SCF. The secreted soluble form of SCF is produced by the proteolytic processing of the cell surface anchored precursor molecule.

Quality description

Research-grade cytokines are suitable for a wide variety of cell culture applications. They are sterile-filtered prior to lyophilization. Generally, endotoxin levels are <0.1 ng/μg (<1 EU/μg), and purities are >95%. The biological activity is tested in appropriate bioassays.

Premium-grade cytokines offer the convenience of high and well-defined biological activities and allow exact unit dosing for demanding applications. The biological activity is determined after lyophilization and reconstitution, and normalized to WHO/NIBSC standards whenever available. In general, endotoxin levels are <0.01 ng/μg (<0.1 EU/μg), and purities are >97%. Lot-specific activities are stated in the Certificate of Analysis (www. miltenyibiotec.com/certificates).

Resources for Human SCF
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for Human SCF
Publications
  1. Laurenti, E. et al. (2015) CDK6 levels regulate quiescence exit in human hematopoietic stem cells. Cell Stem Cell 16 (3): 302-313
  2. Li, J. et al. (2017) Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis. Toxicology 378: 17-24
  3. Zhang, J. et al. (2016) Deregulation of DUX4 and ERG in acute lymphoblastic leukemia. Nat. Genet. 48 (12): 1481-1489
  4. Dighe, N. et al. (2014) Long-term reproducible expression in human fetal liver hematopoietic stem cells with a UCOE-based lentiviral vector. PLoS One 9 (8): e104805
  5. Huan, J. et al. (2015) Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes. Leukemia 29 (12): 2285-2295
  6. Narla, A. et al. (2011) Dexamethasone and lenalidomide have distinct functional effects on erythropoiesis. Blood 118 (8): 2296-2304
  7. Lamsfus-Calle, A. et al. (2020) Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34 + HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin. Sci Rep 10 (1): 10133
  8. Nakazawa, Y. et al. (2016) Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34(+) cells of juvenile myelomonocytic leukemia. J Hematol Oncol. 9: 27
  9. Napolitano, R. et al. (2020) Kevetrin induces apoptosis in TP53 wild‑type and mutant acute myeloid leukemia cells. Oncol Rep 44 (4): 1561-1573
  10. Cypris, O. et al. (2019) Tracking of epigenetic changes during hematopoietic differentiation of induced pluripotent stem cells. Clin Epigenetics 11 (1): 19
  11. Krönke, J. et al. (2015) Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS. Nature 523 (7559): 183-188
  12. Kitumura, T. et al. (1989) Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell. Physiol. 140: 323-334
  13. Brault, J. et al. (2014) Optimized generation of functional neutrophils and macrophages from patient-specific induced pluripotent stem cells: ex vivo models of X0-linked, AR220- and AR470- chronic granulomatous diseases. Biores Open Access 3 (6): 311-326
  14. Arbesu, I. et al. (2016) Platelet-borne complement proteins and their role in platelet-bacteria interactions. J. Thromb. Haemost. 14 (11): 2241-2252
  15. Dussiau, C. et al. (2015) Targeting IRAK1 in T-cell acute lymphoblastic leukemia. Oncotarget. 6: 18956-18965
  16. Steinleitner, K. et al. (2012) EVI1 and MDS1/EVI1 expression during primary human hematopoietic progenitor cell differentiation into various myeloid lineages. Anticancer Res. 32 (11): 4883-4889
  17. Xie, Z. S. et al. (2019) Sphingolipid Modulation Activates Proteostasis Programs to Govern Human Hematopoietic Stem Cell Self-Renewal. Cell Stem Cell 25 (5): 639-653
  18. Velardi, E. et al. (2014) Sex steroid blockade enhances thymopoiesis by modulating Notch signaling. J. Exp. Med. 211 (12): 2341-2349

You have previously chosen International as your location.
What do you want to do?